Abstract:Estrogens are important in regulating mood, especially for females. However, whether tissue-specific estrogen, such as brain estrogen, contributes to the effects of antidepressant treatment has not been determined. The present study used middle-aged aromatase gene knockout (Ar−/-) mice or overexpression (Thy1-Ar; hGFAP-Ar) mice as brain estrogen models to investigate whether brain estrogen synthesis alters the anti-depressive behaviors of sertraline treatment. Our results showed that depletion of brain estrogen increased depressive-like behavior in females, and elevated brain estrogen reduced depression-like behavior, regardless of sex. These genotype-related behaviors correlated with alterations of monoamine metabolism in the hippocampus (HPC) and the prefrontal cortex (PFC). We also demonstrated that male and female Ar−/- mice exhibited an attenuation of sertraline-induced anti-depressive behaviors compared to wild-type (WT) mice. The present data suggest that brain estrogen alters depressive-like behaviors and changes the effectiveness of antidepressants in middle-aged mice, regardless of sex.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore how brain estrogen affects the antidepressant effect of sertraline in middle - aged male and female mice. Specifically, the study investigated whether brain estrogen synthesis alters the antidepressant behavior of sertraline treatment by using aromatase gene - knockout (Ar -/ -) mice or over - expressing (Thy1 - Ar; hGFAP - Ar) mice as brain estrogen models. The research results show that the level of brain estrogen not only affects depressive - like behavior but also changes the efficacy of antidepressant drugs in middle - aged mice, and this effect is not sex - dependent. ### Research Background and Problems 1. **Depression and Gender Differences**: The incidence of depression in women is approximately twice that in men, especially during the postpartum and perimenopausal periods, which may be related to hormonal fluctuations. 2. **The Role of Estrogen**: 17β - estradiol can reverse the depressive - like behavior caused by ovariectomy and relieve perimenopausal - related depressive symptoms. 3. **The Effect of Antidepressants**: Selective serotonin reuptake inhibitors (SSRIs) have significantly better clinical effects on female patients than on male patients, but the opposite is true for tricyclic antidepressants (TCAs). 4. **Brain Estrogen Synthesis**: Brain estrogen is catalytically synthesized by aromatase and is mainly expressed in neurons and astrocytes, affecting non - reproductive behaviors such as cognition and emotion. ### Research Purposes - **Explore the Influence of Brain Estrogen on Depressive - like Behavior**: Through transgenic mouse models, study how brain estrogen affects the depressive - like behavior of middle - aged mice. - **Evaluate the Influence of Brain Estrogen on the Efficacy of Antidepressants**: Through behavioral tests and neurochemical analysis, evaluate how brain estrogen changes the antidepressant effect of sertraline. ### Main Findings - **Absence of Brain Estrogen**: In middle - aged female mice, the absence of brain estrogen increases depressive - like behavior, while in mice with elevated brain estrogen, depressive - like behavior decreases. - **Over - expression of Brain Estrogen**: Regardless of gender, mice with over - expressed brain estrogen exhibit antidepressant behavior. - **The Efficacy of Sertraline**: Sertraline shows antidepressant effects in wild - type (WT) and heterozygous (Ar +/ -) mice, but the effect is weakened in female (Ar -/ -) mice and has no obvious effect in male (Ar -/ -) mice. - **Neurochemical Changes**: The level of brain estrogen affects the metabolism of dopamine (DA), serotonin (5 - HT) and norepinephrine (NE), and these changes are related to antidepressant behavior. ### Conclusions - **The Influence of Brain Estrogen on Depressive - like Behavior**: The level of brain estrogen directly affects the depressive - like behavior of middle - aged mice. - **The Influence of Brain Estrogen on the Efficacy of Antidepressants**: The level of brain estrogen changes the antidepressant effect of sertraline, especially having a more significant impact on female mice. Through these findings, the study provides an important scientific basis for further understanding the role of brain estrogen in the pathogenesis of depression and for developing more effective antidepressant treatment methods.

Brain estrogen alters the effects of the antidepressant sertraline in middle-aged female and male mice

Aromatase Changes in Depression: A Postmortem and Animal Experimental Study.

Estrogen Receptor Α Drives Pro-Resilient Transcription in Mouse Models of Depression.

Effects of estrogen on behavior and monoamine neurotransmitters of brain tissue in depressed mice

Sex Difference in Prebiotics on Gut and Blood-Brain Barrier Dysfunction Underlying Stress-Induced Anxiety and Depression.

Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models

Vortioxetine attenuates the effects of early-life stress on depression-like behaviors and monoamine transporters in female mice

Endogenous Estrogen Influences Predator Odor-Induced Impairment of Cognitive and Social Behaviors in Aromatase Gene Deficiency Mice

Estradiol Reduced 5-HT Reuptake by Downregulating the Gene Expression of Plasma Membrane Monoamine Transporter (PMAT, Slc29a4) Through Estrogen Receptor Β and the MAPK/ERK Signaling Pathway.

Fluoxetine reverses early-life stress-induced depressive-like behaviors and region-specific alterations of monoamine transporters in female mice

Linking alterations in estrogen receptor expression to memory deficits and depressive behavior in an ovariectomy mouse model

Quercetin exerts antidepressant and cardioprotective effects in estrogen receptor α-deficient female mice via BDNF-AKT/ERK1/2 signaling

Relationship of Depression-Like Behavior Induced by Chronic Restraint Stress Estrogen and Hippocampal Estrogen Receptor of Female Mice

The Impact of Depression on Detrimental Changes in Bone Microstructure in Female Mice

Sex-Dependent Effects of Chronic Restraint Stress on Mood-Related Behaviours and Neurochemistry in Mice

Sex differences in a corticosterone-induced depression model in mice: Behavioral, neurochemical, and molecular insights

The alteration of serotonergic markers in the amygdala and raphe nuclei of oestrogen receptor β knock‐out female mice

Sex differences in peripheral monoamine transmitter and related hormone levels in chronic stress mice with a depression-like phenotype

Preventive Effect of Estrogen on Depression-Like Behavior Induced by Chronic Restraint Stress

Subjective experience of the environment determines serotoninergic antidepressant treatment outcome in male mice

Sex‐specific impact of brain estrogen deficiency on astrocyte reactivity, neurodegeneration, and memory loss in aromatase knockout mouse models